Key takeaways
- Cycling is a supraphysiologic bodybuilding concept and does not transfer to therapeutic replacement dosing.
- Suppression is a normal feedback response rather than damage, which is why it is generally reversible.
- hCG alongside therapy maintains intratesticular testosterone and can prevent suppression of sperm production.
- A restart works the testis and the pituitary at the same time, with serial labs to tell slow recovery from none.
- Recovery returns you to your own untreated baseline — not to a better one.
"Should I cycle off?" is one of the most common questions men ask a few months into testosterone therapy, and it usually arrives with an assumption baked in — that staying on continuously is somehow harder on the body than taking breaks. That assumption is inherited from a different practice, aimed at a different problem, using doses several times higher than anything therapeutic. Once you understand what suppression actually is and what a restart actually does, the decision becomes much less mysterious, and much more personal.
Where the idea came from
Cycling is a bodybuilding concept. There, testosterone is used at supraphysiologic doses to drive muscle growth beyond the natural ceiling, and sustained exposure at those levels carries real cardiovascular and haematological costs — so time off is damage limitation. It makes sense for what it is.
Therapeutic testosterone replacement is a different intervention with a different target. The aim is to restore concentrations to the range a healthy man of that age would produce himself, not to exceed it. Endocrine Society guidance frames the whole enterprise as replacement of a deficient hormone in men with confirmed deficiency and symptoms, dosed to a mid-normal target and monitored (Bhasin et al., J Clin Endocrinol Metab 2018). There is no physiological rationale for periodically withdrawing a hormone the body is meant to have.
What suppression actually is
The confusion is worth unpicking, because "shutdown" sounds like damage and it is not.
The hypothalamus releases GnRH in pulses; the pituitary answers with LH and FSH; LH tells Leydig cells to make testosterone and FSH supports the Sertoli cells sustaining sperm production. Circulating testosterone and estradiol feed back to slow the signal. It is a thermostat.
Give exogenous testosterone and the thermostat reads the room as warm. GnRH pulses slow, LH and FSH fall, endogenous production winds down. Nothing has been broken — a control loop has done what it is designed to do. That is also why the testes shrink and why sperm production falls, since spermatogenesis depends on very high testosterone concentrations inside the testis, produced locally under LH rather than delivered by the circulation.
The clinically important implication is that suppression is a functional state, not a structural injury, which is why it is generally reversible and why it can be prevented in the first place. Low-dose hCG given alongside testosterone acts as an LH substitute and maintains intratesticular testosterone during treatment (Coviello et al., J Clin Endocrinol Metab 2005), and continued alongside therapy it preserves spermatogenesis in men who would otherwise be suppressed (Hsieh et al., J Urol 2013). See whether to take hCG with TRT.
Why replacement is usually ongoing
The underlying condition does not usually resolve. Primary hypogonadism does not reverse; age-related decline does not reverse; a pituitary cause does not reverse. The therapy is closer to thyroid replacement than to a training block — supplying something the body is not making enough of, for as long as that remains true.
So stopping returns a man to the state that made him seek treatment. That is not a side effect of stopping; it is the natural history reasserting itself. The relevant comparison is not "on treatment versus normal" but "on treatment versus my own untreated baseline".
Reasons that genuinely justify stopping
- Fertility, when hCG is not an option or has not worked. Active attempts to conceive are the most common legitimate reason. Note that stopping is often unnecessary — see fertility on TRT — but where sperm counts have not recovered on a preserving protocol, coming off is reasonable.
- Erythrocytosis that will not settle. Testosterone stimulates red cell production; where haematocrit stays high despite dose reduction, a change of formulation and therapeutic phlebotomy, discontinuation becomes the correct answer (Ohlander et al., Sex Med Rev 2018). Most cases are manageable without stopping — see haematocrit management.
- A new prostate cancer diagnosis, which is a pause pending urological input rather than an automatic permanent stop; the evidence base here has moved and continues to.
- Genuinely reversible secondary hypogonadism. Obesity-driven suppression, untreated sleep apnoea, opioid use and severe under-eating can all lower testosterone through the axis rather than the testis. If the driver has been removed and sustained, a supervised trial off treatment is a legitimate experiment — and occasionally a successful one.
- Preference. A man may simply decide the injections, the monitoring and the cost are not worth it to him. That is a complete reason. The obligation is only to stop properly rather than abruptly.
Reasons that do not hold up
Three come up repeatedly and are worth naming.
"To give my body a rest." There is nothing to rest from. Physiologic replacement is not a stressor the way supraphysiologic dosing is. What a break produces is a period of symptomatic deficiency followed by a slow return to where you were.
"To restore my natural production." Recovery of the axis restores your own production — which is the production that was inadequate in the first place. If your untreated total testosterone was 300 ng/dL with symptoms, that is the number recovery returns you to.
"To make it work better again." Loss of benefit on stable therapy usually means something else has changed — sleep, body composition, thyroid, alcohol, an unmanaged estradiol picture, or a dosing schedule producing large peaks and troughs. Stopping does not diagnose any of those. Bloodwork does.
What a restart protocol does
If discontinuation is the decision, doing it properly shortens the deficiency and improves the odds of full recovery. The logic is to restart the axis from both ends at once.
- hCG acts at the testis as an LH analogue, waking the Leydig cells directly while the pituitary is still quiet. It works from the bottom up.
- Enclomiphene or clomiphene blocks oestrogen feedback at the hypothalamus, so the brain reads oestrogen as low and increases GnRH, and therefore LH and FSH. That works from the top down.
- hMG, which supplies FSH activity, is reserved for cases where sperm production specifically is not recovering.
- Serial labs — total and free testosterone, LH, FSH, and a semen analysis where fertility is the goal — at intervals through the first few months, because the whole point is to distinguish "recovering slowly" from "not recovering".
Doses and duration are prescribing decisions. The mechanism above is what every reasonable version of the protocol is trying to achieve. Enclomiphene versus TRT covers the same pharmacology used as a primary therapy rather than as an exit.
The recovery timeline, and its honest tail
| Time after stopping | Typical state |
|---|---|
| Week 1-4 | Levels fall to or below the pre-treatment baseline as the exogenous hormone clears and the axis is still quiet. Symptoms are at their worst here. |
| Week 4-12 | LH and FSH begin to rise. Endogenous production resumes but lags the signal. |
| Month 3-6 | Most men are recovering toward baseline. Sperm production, if it was suppressed, is typically returning in this window. |
| Month 6-12 | The large majority have recovered to their own baseline. Integrated analyses of male hormonal suppression and recovery put most men back within a year (Liu et al., Lancet 2006). |
| Beyond 12 months | A minority recover slowly or incompletely. Longer prior duration of use, older age and a lower pre-treatment baseline all predict a slower return. |
The clinical pearl: "restart" means the axis comes back online — not that you arrive somewhere better than where you began. If your pre-treatment testosterone was low and symptomatic, recovery returns you to low and symptomatic. That is the honest frame for the decision, and it is the one most online discussion leaves out.
What stopping actually feels like
Within six weeks most men notice energy and libido falling, flatter mood, and three to eight pounds off the scale — water and glycogen leaving muscle, not fat loss. Over the next three months training capacity declines, recovery lengthens, and body composition drifts back toward its previous set point. Sleep is often the first thing to change and the last thing people connect to the decision.
None of this is dangerous. It is the untreated state arriving over weeks rather than the years it originally took — a fairly direct demonstration of why treatment was started.
Bottom line
Cycling is imported from supraphysiologic use and does not transfer to replacement dosing. Suppression is a predictable feedback response rather than damage, it can often be prevented with hCG, and it reverses in most men over six to twelve months with a properly run restart. Genuine reasons to stop exist — fertility where preservation has failed, unmanageable erythrocytosis, a new prostate diagnosis, a reversible cause that has actually been reversed, or simply not wanting the commitment. "Giving the body a rest" is not one of them. The decision that matters is made before starting: whether the deficiency is real, whether the symptoms match, and whether long-term therapy is something you want. That evaluation belongs with a physician — the 60-second assessment is where it starts.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
